ReGeneraTing Agents (RGTA (®)) are a new option to improve amputation outcomes in the recovery of severe hand injuries

CACIPLIQ20(®) was used to accelerate the healing process and stimulate the viability of flaps and skin grafts, thereby improving amputation outcomes. An excellent range of motion was achieved with hardly any contracture or scarring. Pain relief and reduced sensitivity was noted, while healing of bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Roohi Sharifah, Barritault, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230612/
https://www.ncbi.nlm.nih.gov/pubmed/30455892
http://dx.doi.org/10.1002/ccr3.1797
Descripción
Sumario:CACIPLIQ20(®) was used to accelerate the healing process and stimulate the viability of flaps and skin grafts, thereby improving amputation outcomes. An excellent range of motion was achieved with hardly any contracture or scarring. Pain relief and reduced sensitivity was noted, while healing of bone and tendon also improved, resulting in functional recovery.

Ejemplares similares